Dr. D Prabhakar
Apolipoprotein B
- Measurement of LDL-C and HDL-C are inaccurate, so why measure?
- All the apoB-containing particles are atherogenic; the measurement of apoB encompasses all of them, which must be reduced.
- On treatment, apoB reduction is a better marker. The discordance is more since LDL-C-lowering is more than apoB.
- Both in primary and secondary prevention cohorts – ApoB is better predictor.
- Clear targets, no fasting sample required. Cost is reasonable.
Dr. D Prabhakar
Dr. Prabakar is Consultant Vascular Surgeon at Yashoda Hospital Secunderabad. He Completed MBBS in 1990, Madras Medical College, Chennai. MD (Internal Medicine) in 1992, JIPMER, Pondy, India. DM (Cardiology) in 1998, Madras Medical College, Chennai, India and Assistant Professor of Cardiology, Madras Medical College, Chennai 1998 - 2002. He Has Member in Cardiological Society of India Association of Physicians of India and European Association of Percutaneous Coronary Interventions.
More FAQs by Dr. D Prabhakar
.jpg)
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article